Download PDF
Thromb Haemost 2001; 86(03): 934-935
DOI: 10.1055/s-0037-1616157
Letters to the Editor
Schattauer GmbH

Imbalance towards Th2-Type Response in Patients with Definite Primary Antiphospholipid Syndrome

Ricardo Forastiero
1   Department of Haematology, Thrombosis and Haemostasis, Favaloro University, and Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
,
Marta Martinuzzo
1   Department of Haematology, Thrombosis and Haemostasis, Favaloro University, and Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
,
Luis O. Carreras
1   Department of Haematology, Thrombosis and Haemostasis, Favaloro University, and Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
› Author Affiliations
Further Information

Publication History

Received 18 April 2001

Accepted 23 April 2001

Publication Date:
14 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Vermylen J, Hoylaerts MF, Arnout J. Antibody-mediated thrombosis. Thromb Haemost 1997; 78: 420-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Krause I, Blank M, Levi Y, Koike T, Barak V, Shoenfeld Y. Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol 1999; 190-7.
    PubMedGoogle Scholar
  • 3 Wong CK, Ho CY, Li EK, Lam CWK. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589-93.
    CrossrefPubMedGoogle Scholar
  • 4 Wilson W, Gharavi A, Koike T, Lockshin M, Branch W, Piette J, Brey R, Derksen R, Harris E, Hughes G, Triplett D, Khamashta M. International consensus statement on preliminary classification criteria for definite anti-phospholipid syndrome. Report of an International Workshop. Arthritis Rheum 1999; 42: 1309-11.
    CrossrefPubMedGoogle Scholar
  • 5 Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
    CrossrefPubMedGoogle Scholar
  • 6 Del Papa N, Guidali L, Sala A, Buccellati C, Khamastha MA, Ichikawa K, Tincani A, Balestrieri G, Meroni PL. Endothelial cells as target for anti-phospholipid antibodies. Arthritis Rheum 1997; 40: 551-61.
    CrossrefPubMedGoogle Scholar
  • 7 Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL. Activation of cultured vascular endothelial cells by anti-phospholipid antibodies. J Clin Invest 1995; 96: 2211-9.
    CrossrefPubMedGoogle Scholar
  • 8 Williams FMK, Parmar K, Hughes GRV, Hunt BJ. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost 2000; 84: 742-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 van Aken BE, den Heijer M, Bos GMJ, van Deventer SJH, Reitsma PH. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 2000; 83: 536-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Stouthard JML, Levi M, Hack CE, Veenhot CHN, Romijn HA, Sauerwein HP, van der Poll T. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-42.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Ito H, Matsushita S, Tokano Y, Nishimura H, Tanaka Y, Fujisao S, Mitsuya H, Hashimoto H, Nishimura Y. Analysis of T cell responses to the β2-glycoprotein I-derived peptide library in patients with anti-β2-glycoprotein I antibody-associated autoimmunity. Hum Immunol 2000; 61: 366-77.
    CrossrefPubMedGoogle Scholar
  • 12 Visvanathan S, McNeil HP. Cellular immunity to β2-glycoprotein-I in patients with the antiphospholipid syndrome. J Immunol 1999; 162: 6919-25.
    PubMedGoogle Scholar